In one paragraphArticle in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
5 authors.
Choong-Kun LeeChoong-kun Lee, MD, PhD, Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea, Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea; Sejung Park, PhD, Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea; Chung Mo Nam, PhD, Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea; Hyun Cheol Chung, MD, PhD, Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea, Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea; and Sun Young Rha, MD, PhD, Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea, Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea, Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.ORCID 0000-0001-5151-5096 Sejung ParkChoong-kun Lee, MD, PhD, Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea, Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea; Sejung Park, PhD, Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea; Chung Mo Nam, PhD, Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea; Hyun Cheol Chung, MD, PhD, Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea, Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea; and Sun Young Rha, MD, PhD, Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea, Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea, Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.ORCID 0000-0003-1728-2465 Chung Mo NamChoong-kun Lee, MD, PhD, Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea, Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea; Sejung Park, PhD, Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea; Chung Mo Nam, PhD, Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea; Hyun Cheol Chung, MD, PhD, Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea, Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea; and Sun Young Rha, MD, PhD, Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea, Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea, Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.ORCID 0000-0003-0985-0928 Hyun Cheol ChungChoong-kun Lee, MD, PhD, Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea, Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea; Sejung Park, PhD, Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea; Chung Mo Nam, PhD, Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea; Hyun Cheol Chung, MD, PhD, Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea, Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea; and Sun Young Rha, MD, PhD, Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea, Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea, Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.ORCID 0000-0002-0920-9471 Sun Young RhaChoong-kun Lee, MD, PhD, Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea, Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea; Sejung Park, PhD, Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea; Chung Mo Nam, PhD, Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea; Hyun Cheol Chung, MD, PhD, Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea, Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea; and Sun Young Rha, MD, PhD, Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea, Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea, Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.ORCID 0000-0002-2512-4531 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
What OpenQuestion holds
Textmetadata
Read underepoch 390